This webinar provided an overview of emerging evidence on the effectiveness of COVID-19 vaccinations among care home populations and showcased two studies that are measuring COVID-19 immunity among care home populations in Canada and the UK.

1. What is the evidence on the effectiveness of COVID-19 vaccines for people living in care homes?
2. What do we know about the duration of immunity?
3. What are the implications of what we know so far, and what is the evidence we need in order to address the ongoing challenges posed by COVID-19 in care homes?

Slides and links:

Maximilian Salcher-Konrad (CPEC, Department of Health Policy, London School of Economics)

What evidence on vaccine effectiveness in long-term care populations has been generated?

https://ltccovid.org/2021/04/15/evidence-summary-newly-emerging-evidence-from-three-studies-on-the-protective-effect-of-covid-19-from-infections/

Jorge Browne (MD, MSc. Servicio Nacional del Adulto Mayor, Universidad Católica de Chile)

Epidemiological status of Long Term Care Facilities with high vaccination coverage and high community transmission: the case of Chile

Amy Hsu (Bruyère Research Institute and University of Ottawa Department of Family Medicine)

Initial findings from the C19 Immunity study: Identification of underlying factors influencing the immune response to SARS-CoV-2 among workers and residents in long-term care homes: a multi-province study https://www.c19immunitystudy.ca

Laura Shallcross (UCL, Institute of Health Informatics, UK)

The Vivaldi study: epidemiology of SARS-CoV2 infection amongst care home residents and staff in England: https://www.ucl.ac.uk/health-informatics/research/vivaldi-study